From Fear to Purpose ACT Protocol. Implications of Death Anxiety in Depression and Anxiety Symptoms.

Babes-Bolyai University

Status: Not yet enrolling

Conditions: Death Anxiety; Depression; Anxiety

Treatments: Other: From Fear to Purpose (Acceptance and Commitment Therapy); Other: Placebo

Study type: Interventional

Funder types: Other

Identifiers

NCT06810999

816/22.01.2025

Details and patient eligibility

About

The main purpose of this placebo controlled trial is to test the efficacy of a one-session From Fear to Purpose ACT intervention in reducing self-reported death anxiety levels. Another objective of this study is to investigate whether reductions in death anxiety levels are associated with reductions in depression and anxiety levels, thus testing if death anxiety is a transdiagnostic factor involved in psychopathology.

Full description

This is a placebo controlled trial where the main objective is to test if the one-session From Fear to Purpose ACT intervention is effective in reducing self-reported death anxiety levels. A secondary objective is to investigate whether reductions in death anxiety levels are associated with reductions in depression and anxiety levels, thus testing if death anxiety is a transdiagnostic factor involved in psychopathology.

Participants will be selected based on death anxiety levels (moderate-high scores) and depression and anxiety symptoms (subclinical levels). Minors, people with suicidal ideation, people with current psychological/psychiatric diagnosis (excepting depression or anxiety diagnosis), people in active psychological/psychiatric treatment will be excluded. Recruited participants will be randomized into two groups: the experimental group (will receive the From Fear to Purpose ACT intervention) and the placebo group. The placebo condition will be undergoing a group-based attentional control activity. Participants will be blinded to the study condition.

The From Fear to Purpose intervention protocol is based on Acceptance and Commitment Therapy (ACT) strategies, build around identifying and committing to personal values. The intervention will be group-based (90 minutes session). The intervention will be administered by experienced psychotherapists.

The primary outcome is death anxiety, while secondary outcomes are depression and anxiety symptoms, well-being, psychological flexibility, experiential avoidance and valued living.

Enrollment: 175 estimated patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Moderate-high levels of death anxiety (score > or = 55) AND
• Subclinical levels of depression (score > or = 9) AND/OR
• Subclinical levels of anxiety (score > or = 9)

Exclusion criteria

• Minors
• Suicidal ideation
• Current psychological/psychiatric diagnosis (except depression or anxiety diagnosis)
• Active psychological/psychiatric treatment

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

175 participants in 2 patient groups, including a placebo group

Experimental Group

Experimental group

Description:

This arm is the experimental group which will receive the intervention. The intervention is a one session From Fear to Purpose ACT Protocol, which is built on Acceptance and Commitment Therapy (ACT) strategies, focused on identifying and committing to personal values.

Treatment:

Other: From Fear to Purpose (Acceptance and Commitment Therapy)

Placebo Group

Placebo Comparator group

Description:

This arm is the placebo group, which will be undergoing a group-based attentional control intervention.

Treatment:

Other: Placebo